BIOMAT Database Logo BIOMAT Database Logo

The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents. 1974

K R Adam, and J R Baird, and R A Burges, and J Linnell

UI MeSH Term Description Entries
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D011217 Practolol A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS. Dalzic,Eralzdin Practolol,ICI-50172,ICI 50172,ICI50172,Practolol, Eralzdin
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D003408 Cresols Any of three isomeric crystalline aromatic methylphenols, also known as hydroxytoluenes.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

K R Adam, and J R Baird, and R A Burges, and J Linnell
Beta-adrenergic blockade of the lung. Dose-dependent cardioselectivity of tolamolol in asthma.
June 1978, Chest,
K R Adam, and J R Baird, and R A Burges, and J Linnell
The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.
November 1972, The Journal of pharmacy and pharmacology,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Beta receptor blocking and antiarrhythmic properties of tolamolol.
December 1974, The Journal of pharmacology and experimental therapeutics,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Tolamolol, a beta adrenergic blocking agent: study of its efficacy in angina pectoris.
September 1978, Military medicine,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Pharmacologic aspects of cardioselectivity in a beta-blocking drug.
May 1987, The American journal of cardiology,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.
June 1973, British journal of pharmacology,
K R Adam, and J R Baird, and R A Burges, and J Linnell
A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
August 1987, Journal of cardiovascular pharmacology,
K R Adam, and J R Baird, and R A Burges, and J Linnell
New approach to assessment of cardioselectivity of beta-blocking drugs.
November 1974, British medical journal,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
January 1991, Proceedings of the Western Pharmacology Society,
K R Adam, and J R Baird, and R A Burges, and J Linnell
Cardioselectivity of beta-adrenoceptor blocking agents. 2. Role of the amino group substituent.
May 1983, Journal of medicinal chemistry,
Copied contents to your clipboard!